+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global 3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4857884
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The 3D Printed Drugs Market grew from USD 292.72 million in 2023 to USD 331.22 million in 2024. It is expected to continue growing at a CAGR of 14.26%, reaching USD 744.29 million by 2030.

3D printing of drugs enables personalization, precision, and cost-efficiency in drug manufacturing. The proliferation of 3D printed drugs is transforming the pharmaceutical industry, enabling the design of medications in any desired shape, size, dose, and delivery rate, delivering personalized healthcare for patients. Increased drug discovery and development activities and an inclination towards a personalized medicines approach are raising the need for advanced drug manufacturing techniques such as 3D printing of drugs. However, the high upfront cost of 3D printing technology may adversely impact the production of 3D printed drugs. Moreover, technological advancements in 3D printing technology are expected to enhance drug production efficiency, which is anticipated to expand its use for the development of drugs.

Regional Insights

The Americas have a significant landscape in the 3D-printed drugs market owing to progressive medical research and development, the robust pharmaceutical industry, and the presence of key 3D-printed drug manufacturers. Rising technological advancements and enhanced healthcare infrastructure further advance the market landscape in the region. Europe has observed a significant market for 3D printed drugs, driven by a rising geriatric population, initiatives towards personalized medicine, supportive governmental regulations, and funding activities from government and key manufacturers. In the Middle East & Africa, increasing investments in technological adoption and healthcare infrastructure enhancement contribute to market growth. The Asia-Pacific region is witnessing an emerging stage in the 3D printed drugs market and shows significant growth potential driven by factors such as rapid urbanization, innovations in healthcare technologies, increasing healthcare expenditures, and a rising elderly population requiring customized medication.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the 3D Printed Drugs Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Surge in demand for instantaneous soluble drugs
  • Growing adoption of personalized drugs and the production of combination medicine
  • Extensive use of 3D printed technology for manufacturing cancer drugs

Market Restraints

  • Material limitations associated with manufacturing of 3D printed drugs

Market Opportunities

  • Constant technological developments in 3D printing technique
  • Significant investments for manufacturing of 3D printed pharmaceuticals

Market Challenges

  • Complexities in manufacturing of 3D printed drugs

Market Segmentation Analysis

  • Technology: Direct-write technology provides personalized and effective medication solutions
  • Dose Form: Potential adoption of 3D printed drugs in the form of capsule
  • Application: Proliferating use for manufacturing of neurology drugs
  • End-User: Significant penetration of 3D printed drugs in clinics & hospitals

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the 3D Printed Drugs Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the 3D Printed Drugs Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

CurifyLabs Launches 3D Printing Solution For Personalised Medicine

CurifyLabs introduced GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines, facilitating a novel solution for producing patient-tailored and personalized medicines in pharmacies and hospitals. CurifyLabs’ Pharma Kit, including automated 3D printing technology and printable pharmaceutical inks, allows wider adoption of personalized medicine, resulting in better future care for patients.

Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting

Carcinotech and 3D bioprinting firm CELLINK collaborated to accelerate cancer drug development with 3D bioprinted tumor models. The partnership focuses on the development and commercialization of cutting-edge protocols for the fabrication of 3D bioprinted tumor models using cancer cell lines. These models are designed to significantly improve accuracy and speed up drug development processes, ultimately reducing development costs and enhancing research output.

Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis

Triastek, Inc. received U.S. FDA clearance for its investigational new drug (IND) application for clinical studies of the T21, 3D printed medicine related to potential treatment for ulcerative colitis. T21 is a potential treatment capable of colon-targeted drug delivery. With a unique 3D dosage form design, T21 can reach the targeted colon segment of the GI tract, thus permitting the use of a lower drug dose than the reference-listed drug, which provides systemic exposure.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the 3D Printed Drugs Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology

  • Direct-Write
  • Fused Deposition Modelling
  • Inkjet Printing
  • Powder Bed Printing
  • Stereolithography
  • Zip Dose

Dose Form

  • Capsule
  • Nanoparticles
  • Tablet

Application

  • Dental
  • Neurology
  • Orthopedic

End-User

  • Clinics & Hospitals
  • Research Laboratories
  • Speciality Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in demand for instantaneous soluble drugs
5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
5.1.2. Restraints
5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
5.1.3. Opportunities
5.1.3.1. Constant technological developments in 3D printing technique
5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
5.1.4. Challenges
5.1.4.1. Complexities in manufacturing of 3D printed drugs
5.2. Market Segmentation Analysis
5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
5.2.3. Application: Proliferating use for manufacturing of neurology drugs
5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. 3D Printed Drugs Market, by Technology
6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose
7. 3D Printed Drugs Market, by Dose Form
7.1. Introduction
7.2. Capsule
7.3. Nanoparticles
7.4. Tablet
8. 3D Printed Drugs Market, by Application
8.1. Introduction
8.2. Dental
8.3. Neurology
8.4. Orthopedic
9. 3D Printed Drugs Market, by End-User
9.1. Introduction
9.2. Clinics & Hospitals
9.3. Research Laboratories
9.4. Speciality Clinics
10. Americas 3D Printed Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific 3D Printed Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa 3D Printed Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
13.3.2. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
13.3.3. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. 3D PRINTED DRUGS MARKET DYNAMICS
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 118. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 119. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 126. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 127. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 142. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 143. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 190. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 191. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 224. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 225. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 232. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 233. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 238. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 239. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 240. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 241. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 248. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 249. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 262. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 263. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 264. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 265. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 286. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 287. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 288. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 289. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 296. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 297. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 304. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 305. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 334. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 335. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 336. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 337. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 340. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 356. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 357. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 358. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 359. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 360. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
TABLE 361. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 362. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 363. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 364. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
TABLE 3

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Systems, Inc.
  • 3DR HOLDINGS
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • AstraZeneca plc
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • Cycle Pharmaceuticals
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • GlaxoSmithKline Plc
  • Materialise NV
  • Merck KGaA
  • Organovo Holdings Inc.
  • Proto Labs Inc.
  • Renishaw PLC
  • Rokit Healthcare Inc.
  • Siemens AG
  • Stratasys Ltd.
  • Triastek, Inc.
  • TVASTA
  • Yissum
  • Zortrax S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 331.22 Million
Forecasted Market Value ( USD ) by 2030 $ 744.29 Million
Compound Annual Growth Rate14.2%
Regions CoveredGlobal

Related Topics

Related Reports

Global 3D Printed Drugs Market Analysis & Forecast to 2024-2034: Market By Technology; By Application; By End-user; and By Region - Product Image

Global 3D Printed Drugs Market Analysis & Forecast to 2024-2034: Market By Technology; By Application; By End-user; and By Region

  • Report
  • 200 Pages
  • Global
From
3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 81 Pages
  • Global
From
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 317 Pages
  • Global
From
Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 140 Pages
  • Asia Pacific
From
Medical Modeling. The Application of Advanced Design and Additive Manufacturing Techniques in Medicine. Edition No. 3. Woodhead Publishing Series in Biomaterials - Product Image

Medical Modeling. The Application of Advanced Design and Additive Manufacturing Techniques in Medicine. Edition No. 3. Woodhead Publishing Series in Biomaterials

  • Book

About the 3D Printed Drug Market

The 3D Printed Drug market is a subset of the Pharmaceutical industry that focuses on the production of drugs using 3D printing technology. This technology allows for the production of drugs with complex geometries and shapes, as well as the ability to customize drugs for individual patients. 3D Printed Drugs are typically produced using a powder-based process, where a powder is spread over a build platform and then fused together using a laser. This process allows for the production of drugs with a high degree of accuracy and precision. The 3D Printed Drug market is expected to grow in the coming years, as the technology becomes more widely adopted. This growth is driven by the potential for improved drug efficacy, as well as the ability to customize drugs for individual patients. Some companies in the 3D Printed Drug market include Aprecia Pharmaceuticals, 3DPharma, and 3D4MD. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.